Form 8-K - Current report:
SEC Accession No. 0001493152-22-017652
Filing Date
2022-06-24
Accepted
2022-06-24 08:05:38
Documents
17
Period of Report
2022-06-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 62686
2 ex10-1a.htm EX-10.1A 103819
3 ex10-1b.htm EX-10.1B 54574
4 ex10-1c.htm EX-10.1C 54362
5 ex99-1.htm EX-99.1 26323
6 ex99-1_001.jpg GRAPHIC 13346
  Complete submission text file 0001493152-22-017652.txt   549463

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE dare-20220623.xsd EX-101.SCH 2977
8 XBRL LABEL FILE dare-20220623_lab.xml EX-101.LAB 34916
9 XBRL PRESENTATION FILE dare-20220623_pre.xml EX-101.PRE 22801
11 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3639
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

EIN.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36395 | Film No.: 221036998
SIC: 2834 Pharmaceutical Preparations